Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday.

The Carlyle Group and SK Capital Partners have agreed to acquire bluebird bio, Inc, a Somerville, Massachusetts-based gene therapy firm, in a take-private deal. According to terms of the agreement, ...

The best dishes Rough Draft Dining Editor Beth McKibben ate from Atlanta restaurants in February 2025 included the Little Gem ...

There is a catch. If the private equity firms can boost sales of bluebird’s three gene therapies to $600 million—over any ...

Bluebird Bio announced Friday it would sell itself and its portfolio of gene therapies to the investment firms Carlyle and SK ...

Gene therapy developer bluebird bio (NASDAQ:BLUE) announced Friday its plans to become a privately held biotech as part of an M&A agreement with private equity firms, Carlyle Group (NASDAQ:CG) and SK ...

The agreement, which also includes a team of biotech executives, will see Bluebird Bio’s stockholders receive $3.00 per share ...

There has only been one albino western lowland gorilla ever found in the wild or captivity. Snowflake the gorilla lived in ...

One of the comedy breakouts of 2023 was Jury Duty, a documentary-style comedy for Amazon Freevee that featured James Mardsen and other actors surrounding an unsuspecting juror at a trial. The ...

Ancient DNA is telling us more and more about humans and environments long past. Could it also help rescue the future?